Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9288365Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$402.6K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#23,087
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Anthony Folawuyi Daniyan as a PI. Multi-PI records show the full award amount for context.
- 5R01CA291796-02R01Development of chimeric antigen receptor T cells targeting cell surface U5 snRNP for the treatment of acute myeloid leukemia$402.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing Anthony Folawuyi Daniyan as a PI.
FY2026 award administered by Memorial Sloan Kettering Cancer Center (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardMemorial Sloan Kettering Cancer Center
- 2025R01 Grant Holder
- 2026$500K Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Anthony Folawuyi Daniyan.